Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E9CC
|
|||
Former ID |
DNCL002645
|
|||
Drug Name |
Ombrabulin
|
|||
Synonyms |
AVE8062
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Sarcoma [ICD-11: 2A60-2C35; ICD-10: C81-C86; ICD-9: 202.8] | Phase 3 | [1] | |
Company |
Sanofi
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H26N2O6
|
|||
Canonical SMILES |
COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)NC(=O)C(CO)N
|
|||
InChI |
1S/C21H26N2O6/c1-26-17-8-7-13(9-16(17)23-21(25)15(22)12-24)5-6-14-10-18(27-2)20(29-4)19(11-14)28-3/h5-11,15,24H,12,22H2,1-4H3,(H,23,25)/b6-5-/t15-/m0/s1
|
|||
InChIKey |
IXWNTLSTOZFSCM-YVACAVLKSA-N
|
|||
CAS Number |
CAS 181816-48-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00699517) A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.